Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG).

× No keyword cloud information.

10 in total

Review 1. [Bone metabolism: molecular mechanisms].

Authors: E Neumann; G Schett
Journal: Z Rheumatol Date: 2007-07 Impact factor: 1.372

Review 2. [Rheumatism and bone metabolism].

Authors: G Dischereit; U Lange
Journal: Orthopade Date: 2019-11 Impact factor: 1.087

3. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].

Authors: E Neumann
Journal: Z Rheumatol Date: 2006-09 Impact factor: 1.372

4. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease.

Authors: Tiziana Larussa; Evelina Suraci; Immacolata Nazionale; Isabella Leone; Tiziana Montalcini; Ludovico Abenavoli; Maria Imeneo; Arturo Pujia; Francesco Luzza
Journal: World J Gastroenterol Date: 2012-04-14 Impact factor: 5.742

Review 5. [Inflammation and bone metabolism].

Authors: E Neumann; U Müller-Ladner; K W Frommer
Journal: Z Rheumatol Date: 2014-05 Impact factor: 1.372

Review 6. Osteoporosis in celiac disease and in endocrine and reproductive disorders.

Authors: Anna-Velia Stazi; Antonello Trecca; Biagino Trinti
Journal: World J Gastroenterol Date: 2008-01-28 Impact factor: 5.742

7. Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists.

Authors: Isidoro González-Alvaro; Ana M Ortiz; Eva G Tomero; Alejandro Balsa; Javier Orte; Armando Laffon; Rosario García-Vicuña
Journal: Ann Rheum Dis Date: 2007-07-31 Impact factor: 19.103

8. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.

Authors: Andrea Callegari; Matthew L Coons; Jerry L Ricks; Michael E Rosenfeld; Marta Scatena
Journal: J Vasc Res Date: 2014-03-07 Impact factor: 1.934

9. Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway.

Authors: Xinyue Xu; Yizhou Tang; Yuanyuan Lang; Yanling Liu; Wenshu Cheng; Hengyi Xu; Yang Liu
Journal: Int J Nanomedicine Date: 2020-12-03

Review 10. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.

Authors: Theodoros Kelesidis; Judith S Currier; Otto O Yang; Todd T Brown
Journal: AIDS Rev Date: 2014 Jul-Sep Impact factor: 2.381

10 in total